Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Preveceutical Medical Inc C.PREV

Alternate Symbol(s):  PRVCF

PreveCeutical Medical Inc. is a Canada-based health sciences company. The Company’s principal business activity is the development of options for preventive and curative therapies utilizing organic and nature identical products. The Company’s pipeline includes Cannabinoid Sol-Gel, Non-Addictive Analgesic, BSV Peptide Program and Dual Gene Therapy. Its Cannabinoid Sol-Gel is a cannabinoid-based nose-to-brain delivery system that provides relief to a range of indications from pain, inflammation, seizures, and neurological disorders. Its Dual Gene Therapy for curative and prevention therapies for diabetes and obesity. Its Nature Identical peptides for treatment of various ailments. Its BSV peptide program targets cancer progression. Its nonaddictive analgesic peptides as a replacement to the highly addictive analgesics such as morphine, fentanyl and oxycodone and a therapeutic product for treating athletes who suffer from concussions (mild traumatic brain injury).


CSE:PREV - Post by User

Preveceutical Medical Inc
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(24)
•••
Post by bveilleuon Mar 16, 2021 9:25pm
351 Views
Post# 32813862

Keith Anderson: Compensation for services... Not bad!

Keith Anderson: Compensation for services... Not bad!
Filed 2021-03-15 13:25
 
Tx date 2021-03-12		 $PREV
PreveCeutical Medical Inc. (formerly, Carrara Exploration Corp.)		 Anderson, Keith
4 - Director of Issuer
Direct Ownership
Common Shares Without Par Value or Special Rights or Restrictions attached
46 - Compensation for services		 $52,500
+1,640,625 vol
$0.032 each		 1,640,625  
Filed 2021-03-15 13:18
 
Tx date 2019-06-21		 $PREV
PreveCeutical Medical Inc. (formerly, Carrara Exploration Corp.)		 Anderson, Keith
4 - Director of Issuer
Direct Ownership
Common Shares Without Par Value or Special Rights or Restrictions attached
00 - Opening Balance-Initial SEDI Report
 

<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities